The New-Onset Diabetes Cohort Study is designed to help develop and test early detection tests and processes. Kaiser Permanente Northern California is collaborating in this multi-site study to identify, recruit, and follow up with members who have recently been identified as having a dysglycemia or new-onset diabetes. Participants will be asked to provide questionnaire data and biospecimens over a three-year period. Patients who complete a baseline visit will receive a $50 gift card and an additional card for each follow-up visit completed and verified.
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer (CPDPC) and the National Community Oncology Research Program (NCORP)
Investigator: Van Den Eeden, Stephen
Funder: National Cancer Institute